INO News and Press, Inovio Pharmaceuticals Inc. From 04/29/24

INOVIO to Report First Quarter 2024 Financial Results on May 13, 2024 PR Newswire PLYMOUTH MEETING, Pa. , April 29, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat a...

2024-04-24 08:37:01 ET Summary Inovio Pharmaceuticals specializes in DNA-based immunotherapies for HPV-related conditions, cancer, and infectious diseases. The company's flagship drug, INO-3107, shows promise for treating recurrent respiratory papillomatosis and VGX-3100 for HPV-r...

2024-04-23 08:29:36 ET Summary Inovio Pharmaceuticals has once again diluted its stock at far below market prices, killing its recent rally. INO's latest try at bringing a treatment to market is INO-3107, for which it expects to submit a BLA in the second half of 2024. Potenti...

Elimination of restrictive borrowing facility provides for more efficient debt capacity and cash management Inseego Corp. (Nasdaq: INSG) (the “Company”), a technology leader in 5G mobile and fixed wireless solutions for mobile network operators, Fortune 500 enterprises, an...

A look at the top 10 most actives in the United States SiNtx Technologies Inc. (SINT) rose 62.9% to $0.0373 on volume of 466,310,671 shares INVO BioScience Inc. (INVO) rose 139.5% to $1.82 on volume of 225,666,770 shares PROSHARES TRUST (SQQQ) rose 3.7% to $11.86 on volume of 167,545,988 ...

A look at the top 10 most actives in the United States Jaguar Health Inc. (JAGX) fell 0.7% to $0.177 on volume of 56,661,669 shares INVO BioScience Inc. (INVO) rose 233.6% to $2.535 on volume of 49,222,014 shares WiSA Technologies Inc. (WISA) rose 51.8% to $9.26 on volume of 27,894,316 sh...

2024-04-16 07:48:19 ET More on Inovio Pharmaceuticals Inovio Pharmaceuticals, Inc. (INO) Q4 2023 Earnings Call Transcript Inovio Pharmaceuticals, Inc. (INO) CEO Jacque Shea Presents at Oppenheimer 34th Annual Healthcare Life Sciences Conference Transcript Inovio: Pla...

INOVIO Announces Pricing of Approximately $36 Million Underwritten Offering of Common Stock and Pre-Funded Warrants PR Newswire PLYMOUTH MEETING, Pa. , April 15, 2024 /PRNewswire/ -- INOVIO Pharmaceuticals, Inc. ( Nasdaq : INO ), a biotechnology com...

Inseego Corp. (Nasdaq: INSG), a technology leader in 5G and 4G mobile and fixed wireless solutions for mobile network operators, Fortune 500 enterprises and SMBs, today announced that the company will release its financial results for the first quarter of 2024, ended March 31, 2024, after the fin...

2024-04-07 01:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...